Li-Ting Kao

30PUBLICATIONS
39CO-AUTHORS
Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 29, 2026
Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses.

|Sep 14, 2026
Post-traumatic stress disorder and adverse pregnancy and birth outcomes: a population-based study.

|May 06, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

|Dec 09, 2025
Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes.

Ren-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen

|Nov 17, 2025
Healthcare utilization in cancer patients treated with immune checkpoint inhibitors: a population-based study of all patients and 1-year survivors.

Chia-Lu Hsu, Li-Fan Hsu, Sheng-Yin To

|Oct 09, 2025
Sodium-Glucose Cotransporter 2 Inhibitors and Lower Risk of Depression in Population with Type 2 Diabetes Mellitus: A Population-Based Active Comparator, New-User Design.

Ming-Jyun Kao, Ying-Chih Huang, Yu-Chieh Huang

Pageof 5

Frequent Collaborators

5 joint publications

Sheng-Yin To

4 joint publications

Hui-Wen Yang

3 joint publications

Cho-Hao Lee

3 joint publications

Po-Huang Chen